TheEdgeResearch
Home / Stocks / VSEE

VSee Health, Inc. (VSEE)

NASDAQ Healthcare Medical - Healthcare Information Services
$0.05 ▲ +52.12%
Market Cap
$816,478
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
0.49
52-Wk Range
0.005-2.52
CEO
Imoigele Aisiku
Country
US
Currency
USD

VSee Health, Inc. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Newton, MA, US. The stock last traded at $0.05, up 52.12% on the session, giving a market capitalisation of $816,478. On trailing twelve-month figures it carries a trailing P/E of -0.09, a net margin of -92.4%. Its beta of 0.49 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.09
Price / Sales
0.06
Price / Book
0.38
EV / EBITDA
-0.19
Gross margin
46.3%
Operating margin
-66.2%
Net margin
-92.4%
Return on equity
Debt / equity
0.34
Current ratio
0.41
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
209
IPO date
2021-12-31
Headquarters
Newton, MA, US
About VSee Health, Inc.

VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.

Comparable companies

VSee Health, Inc. is most often compared with the following Healthcare names:

ADGMALURAPLMATHABCTXCOCHCTXRHCTILPTXMBRX
More research on VSEE
VSEE technical analysis VSEE TheEdge Score Compare against peers
Open full interactive analysis & DCF →